140 related articles for article (PubMed ID: 32624524)
1. Prognosis and Clinical Characteristics of Dilated Cardiomyopathy With Family History via Pedigree Analysis.
Marume K; Noguchi T; Tateishi E; Morita Y; Miura H; Nishimura K; Ohta-Ogo K; Yamada N; Tsujita K; Izumi C; Kusano K; Ogawa H; Yasuda S
Circ J; 2020 Jul; 84(8):1284-1293. PubMed ID: 32624524
[TBL] [Abstract][Full Text] [Related]
2. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.
Becker MAJ; Cornel JH; van de Ven PM; van Rossum AC; Allaart CP; Germans T
JACC Cardiovasc Imaging; 2018 Sep; 11(9):1274-1284. PubMed ID: 29680351
[TBL] [Abstract][Full Text] [Related]
4. Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement.
Halliday BP; Baksi AJ; Gulati A; Ali A; Newsome S; Izgi C; Arzanauskaite M; Lota A; Tayal U; Vassiliou VS; Gregson J; Alpendurada F; Frenneaux MP; Cook SA; Cleland JGF; Pennell DJ; Prasad SK
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1645-1655. PubMed ID: 30219397
[TBL] [Abstract][Full Text] [Related]
5. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
[TBL] [Abstract][Full Text] [Related]
6. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.
Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
Tateishi E; Noguchi T; Goto Y; Morita Y; Ishibashi-Ueda H; Yamada N; Kanzaki H; Nishimura K; Miyamoto Y; Anzai T; Ogawa H; Yasuda S
Heart; 2015 May; 101(10):774-80. PubMed ID: 25761994
[TBL] [Abstract][Full Text] [Related]
8. Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy.
Chimura M; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
PLoS One; 2019; 14(6):e0217865. PubMed ID: 31220100
[TBL] [Abstract][Full Text] [Related]
9. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR Group.
Alba AC; Gaztañaga J; Foroutan F; Thavendiranathan P; Merlo M; Alonso-Rodriguez D; Vallejo-García V; Vidal-Perez R; Corros-Vicente C; Barreiro-Pérez M; Pazos-López P; Perez-David E; Dykstra S; Flewitt J; Pérez-Rivera JÁ; Vazquez-Caamaño M; Katz SD; Sinagra G; Køber L; Poole J; Ross H; Farkouh ME; White JA
Circ Cardiovasc Imaging; 2020 Apr; 13(4):e010105. PubMed ID: 32312112
[TBL] [Abstract][Full Text] [Related]
11. Value of Speckle Tracking-Based Deformation Analysis in Screening Relatives of Patients With Asymptomatic Dilated Cardiomyopathy.
Verdonschot JAJ; Merken JJ; Brunner-La Rocca HP; Hazebroek MR; Eurlings CGMJ; Thijssen E; Wang P; Weerts J; van Empel V; Schummers G; Schreckenberg M; van den Wijngaard A; Lumens J; Brunner HG; Heymans SRB; Krapels IPC; Knackstedt C
JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 2):549-558. PubMed ID: 31202754
[TBL] [Abstract][Full Text] [Related]
12. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.
Romano S; Judd RM; Kim RJ; Kim HW; Klem I; Heitner JF; Shah DJ; Jue J; White BE; Indorkar R; Shenoy C; Farzaneh-Far A
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1419-1429. PubMed ID: 29361479
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
[TBL] [Abstract][Full Text] [Related]
15. Fat deposition in dilated cardiomyopathy assessed by CMR.
Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
[TBL] [Abstract][Full Text] [Related]
16. Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy.
Ikeda Y; Inomata T; Fujita T; Iida Y; Nabeta T; Ishii S; Maekawa E; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Ako J
Heart Vessels; 2016 Nov; 31(11):1817-1825. PubMed ID: 26843195
[TBL] [Abstract][Full Text] [Related]
17. Long term prognostic importance of late gadolinium enhancement in first-presentation non-ischaemic dilated cardiomyopathy.
Sree Raman K; Nucifora G; Leong DP; Marx C; Shah R; Woodman RJ; Molaee P; Shirazi MG; McGavigan AD; De Pasquale CG; Selvanayagam JB
Int J Cardiol; 2019 Apr; 280():124-129. PubMed ID: 30679073
[TBL] [Abstract][Full Text] [Related]
18. Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy.
Kodama S; Kato S; Hayakawa K; Azuma M; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kosuge M; Kimura K; Tamura K
Heart Vessels; 2020 Oct; 35(10):1439-1445. PubMed ID: 32417957
[TBL] [Abstract][Full Text] [Related]
19. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
[TBL] [Abstract][Full Text] [Related]
20. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
